Claman Countdown | Latest Episodes

NFJ Investment Group CIO John Mowrey analyzes Amazon’s growth outlook and explains how AWS strengthens the company amid broader technology market volatility on ‘The Claman Countdown.’

Meridian Equity Partners senior managing partner Jonathan Corpina discusses investors' perspective amid the U.S.-Iran conflict on 'The Claman Countdown.'

SPAN Founder and CEO Arch Rao discusses XFRA, a self-cooling backyard node that taps excess residential solar power to fuel decentralized AI data centers on ‘The Claman Countdown.’

Columbia Threadneedle head of North American equities Nicolas Janvier discusses opportunities in small-cap stocks, the performance of the Russell 2000, and his top stock picks on 'The Claman Countdown.'

Fox News media and political analyst Howard Kurtz discusses Paramount CEO David Ellison considering a move out of California on 'The Claman Countdown.'

Bilt founder and CEO Ankur Jain discusses how the company allows users to earn rewards on rent and mortgage payments on ‘The Claman Countdown.’

Prosper Trading Academy CEO Scott Bauer discusses retail investors' appetite for upside and downside protection in the market on 'The Claman Countdown.'

Amazon Web Services CEO Matt Garman discusses the cloud giant’s AI-driven drug discovery partnership with Novo Nordisk on ‘The Claman Countdown.’

The Fitz-Gerald Group principal Keith Fitz-Gerald unpacks SpaceX's performance on 'The Claman Countdown.'

Armadin founder and CEO Kevin Mandia breaks down how North Korean cybercriminals are using A.I. to secure jobs in the United States on ‘The Claman Countdown.’

Crossmark Global Investments CEO Bob Doll discusses whether investors should trim risk in a volatile stock market amid rising Treasury yields and geopolitical tension on ‘The Claman Countdown.’

Apollon Wealth Management CIO Eric Sterner joins Liz Claman to discuss the healthcare sector's recent surge. He explains how AI integration and a five-year high in M&A activity are driving massive tailwinds for biotech and pharmaceutical stocks.

Sky Harbour Group CEO Tal Keinan opens up about the company's services on 'The Claman Countdown.'

Apollon Wealth Management CIO Eric Sterner discusses how technology is driving gains in the healthcare sector on ‘The Claman Countdown.’

Cerebras Systems co-founder and CEO Andrew Feldman discusses the company’s Q2 earnings, its WSE AI chip and its $20 billion partnership with OpenAI on ‘The Claman Countdown.’

UBS managing director and senior portfolio manager Jason Katz discusses how he is viewing the market on 'The Claman Countdown.'

Republic Services president and CEO Jon Vander Ark discusses the recycling industry's transformation and the European Union's new packaging regulations on ‘The Claman Countdown.’

Elanco Animal Health president and CEO Jeff Simmons discusses how his company is helping combat the screwworm outbreak in the United States on 'The Claman Countdown.'

Raymond James Investment Management chief market strategist Matt Orton discusses the market rally, AI-driven growth, where he sees investment opportunities and why investors should look for 'bottlenecks' on ‘The Claman Countdown.’

Tortoise Capital senior portfolio manager Brian Kessens discusses whether energy stocks are overvalued on ‘The Claman Countdown.’